Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $71.8200 (0.06%) ($71.8200 - $72.5700) on Wed. Jun. 28, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.38% (three month average) | RSI | 52 | Latest Price | $71.8200(0.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.4% a day on average for past five trading days. | Weekly Trend | LGND declines -0.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(46%) IBB(43%) XAR(42%) IWO(37%) VFMO(37%) | Factors Impacting LGND price | LGND will decline at least -1.19% in a week (0% probabilities). VXX(-22%) UUP(-18%) TBT(-18%) VIXM(-8%) XLU(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.19% (StdDev 2.38%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $74 | 5 Day Moving Average | $72.9(-1.48%) | 10 Day Moving Average | $75.11(-4.38%) | 20 Day Moving Average | $74(-2.95%) | To recent high | -9.8% | To recent low | 3% | Market Cap | $1.154b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |